Toggle light / dark theme

New Drug Exposes Hidden Subtypes of Psychosis

A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the first new schizophrenia drug mechanism approved in 50 years.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */